| Original language | English (US) |
|---|---|
| Pages (from-to) | 242-246.e5 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 128 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 2011 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology, Vol. 128, No. 1, 07.2011, p. 242-246.e5.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis
AU - De Benedetto, Anna
AU - Slifka, Mark K.
AU - Rafaels, Nicholas M.
AU - Kuo, I. Hsin
AU - Georas, Steve N.
AU - Boguniewicz, Mark
AU - Hata, Tissa
AU - Schneider, Lynda C.
AU - Hanifin, Jon
AU - Gallo, Richard L.
AU - Johnson, David C.
AU - Barnes, Kathleen C.
AU - Leung, Donald Y.M.
AU - Beck, Lisa A.
N1 - Funding Information: Supported by the Atopic Dermatitis and Vaccinia Network NIH/NIAID (contract nos. N01 AI40029 and N01 AI40033 ) and the Atopic Dermatitis Research Network (contract nos. HHSN272201000020C and HHSN272201000017C ), the National Eczema Association (A.D.), the Oregon National Primate Research Center grant ( RR000163 ; M.K.S.), and the Mary Beryl Patch Turnbull Scholar Program (K.C.B.). Funding Information: Disclosure of potential conflict of interest: A. De Benedetto has received research support from the National Eczema Association , the National Institutes of Health/National Institute of Allergy and Infectious Diseases , and Centocor Inc , and training grant ( DHHS/PHS/NIH 5 T32 AR007472-21 ; Kirschstein-NRSA). M. Boguniewicz has received research support from the National Institutes of Health . L. C. Schneider has received research support from Astellas and Novartis . J. M. Hanifin is a member of the National Eczema Association Board of Directors. K. C. Barnes has received research support from the National Institutes of Health and Sanofi-Aventis . L. A. Beck is a Regeneron Consultant and has received research support from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, the National Eczema Association, and Centocor Inc . The rest of the authors have declared that they have no conflict of interest.
PY - 2011/7
Y1 - 2011/7
UR - http://www.scopus.com/inward/record.url?scp=79959370617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959370617&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2011.02.014
DO - 10.1016/j.jaci.2011.02.014
M3 - Article
C2 - 21489616
AN - SCOPUS:79959370617
SN - 0091-6749
VL - 128
SP - 242-246.e5
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -